Yeungnam Univ J Med.  2014 Jun;31(1):28-32.

Treatment of pulmonary thromboembolism using Arrow-Trerotola percutaneous thrombolytic device

Affiliations
  • 1Department of Cardiology, Eulji General Hospital, Eulji University, Seoul, Korea. cisamoe@gmail.com
  • 2Division of Cardiology, Department of Internal Medicine, College of Medicine, Yeungnam University, Daegu, Korea.

Abstract

Pulmonary thromboembolism (PTE) increases the pressure of the right ventricle and leads to symptoms and signs, such as dyspnea and hypoxia. If PTE causes hemodynamic instability, thrombolytic therapy should be considered. A mechanical thrombectomy is an alternative treatment to thrombolytic therapy and should be considered when thrombolytic therapy is contraindicated. Various devices are used in mechanical maceration and catheter-directed thrombolysis, but there is no standard mechanical device for PTE as yet. We report here on 2 clinical experiences of mechanical thrombectomy using the Arrow-Trerotola percutaneous thrombolytic device to remove residual clots after systemic thrombolysis in patients with massive PTE.

Keyword

Pulmonary embolism; Mechanical thrombectomy; Trerotola

MeSH Terms

Anoxia
Dyspnea
Heart Ventricles
Hemodynamics
Humans
Pulmonary Embolism*
Thrombectomy
Thrombolytic Therapy
Full Text Links
  • YUJM
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr